Heparin Cofactor II Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly Individuals

Circulation - United States
doi 10.1161/01.cir.0000129968.46095.f3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Heparin Cofactor II in Atherosclerotic Lesions From the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2009English

Enhancement of Heparin Cofactor II Anticoagulant Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Is Self-Reported Insomnia a Risk Factor for Subclinical Carotid Atherosclerosis?

Arterial Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Is Physical Activity a Protective Factor Against Pancreatic Cancer?

Bratislava Medical Journal
2014English

Homocysteine Is Not a Risk Factor for Subclinical Coronary Atherosclerosis in Asymptomatic Individuals

PLoS ONE
Multidisciplinary
2020English

Consumption of Fruit and Berries Is Inversely Associated With Carotid Atherosclerosis in Elderly Men

British Journal of Nutrition
MedicineNutritionDietetics
2008English

Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2004English

Association of Plasma Homocysteine Concentrations With Carotid Atherosclerosis in Elderly Japanese.

Internal Medicine
Internal MedicineMedicine
2001English

Studies on the Effect of Calcium in Interactions Between Heparin and Heparin Cofactor II Using Surface Plasmon Resonance

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy